US equities
|
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
META
$741.90
▲+1.90%
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
META
$741.90
▲+1.90%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Clene Inc. - Common Stock
(NQ:
CLNN
)
3.910
-0.170 (-4.17%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Clene Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Builds Momentum to Bring New Hope to Neuro Patients
July 25, 2025
Via
Investor Brand Network
12 Health Care Stocks Moving In Friday's After-Market Session
↗
July 18, 2025
Via
Benzinga
Individuals Who Develop Multiple Sclerosis Have More Doctor Visits Decades Before Their Diagnosis
July 18, 2025
Via
Investor Brand Network
Preclinical Study Finds a Way to Reverse Symptoms of Parkinson’s in Mice
July 08, 2025
Via
Investor Brand Network
Clene Inc. (NASDAQ: CLNN) to Conduct Neurofilament Biomarker Analysis for CNM-Au8(R) in ALS in Early Q4 2025
July 07, 2025
Via
Investor Brand Network
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) Advances Regulatory Strategy for CNM-Au8 with FDA Meetings Scheduled for ALS and MS Programs
June 30, 2025
Via
Investor Brand Network
Why Public Interest in Mitochondrial Function Testing is Growing
June 26, 2025
Via
Investor Brand Network
Q2 Virtual Investor Summit: Presentations Available Now
June 25, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Monday's After-Market Session
↗
June 16, 2025
Via
Benzinga
Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream
↗
June 13, 2025
Via
Stocktwits
Study Finds Kids with MS Biologically Age Faster Than Those Without It
June 12, 2025
Via
Investor Brand Network
InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) CEO Rob Etherington to Present at June 10 Investor Summit Virtual
June 09, 2025
Via
Investor Brand Network
Clene Inc. Chief Executive Officer Rob Etherington to Present at the Investor Summit Virtual on June 10, 2025
June 09, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
June 03, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
June 03, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
June 02, 2025
Via
Benzinga
Study Links Autism to Increased Risk of Developing Parkinson’s Disease
May 30, 2025
Via
Investor Brand Network
Researchers Discover Potential Missing Connection Between EBV and Multiple Sclerosis
May 20, 2025
Via
Investor Brand Network
Eye Exam Could Help in Detecting Parkinson’s Disease Early, Study Suggests
May 08, 2025
Via
Investor Brand Network
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Reports Q1 Results, Advances CNM-Au8 Toward Potential Accelerated Approval for ALS
May 08, 2025
Via
Investor Brand Network
InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Participate in D. Boral Capital Global Conference on May 14
May 07, 2025
Via
Investor Brand Network
Scientists ID Bacteria That Could Be Behind Multiple Sclerosis Development
April 25, 2025
Via
Investor Brand Network
InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Reports Evidence of Remyelination, Cognitive and Visual Gains in MS Trial
April 08, 2025
Via
Investor Brand Network
Study Suggests Possible Link Between ADHD and Heightened Dementia Risk
April 03, 2025
Via
Investor Brand Network
Clene Inc. (NASDAQ: CLNN) to Share CNM-Au8(R) Progress at Jones Las Vegas Conference
April 02, 2025
Via
Investor Brand Network
InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present at Jones Healthcare and Technology Innovation Conference on April 9
April 01, 2025
Via
Investor Brand Network
Clene Inc.’s (NASDAQ: CLNN) Q1 Virtual Investor Summit Presentation Available for On-Demand Viewing
March 27, 2025
Via
Investor Brand Network
New Study Finds Possible Explanation for Higher Parkinson’s Prevalence in Men
March 25, 2025
Via
Investor Brand Network
InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present at Jones Las Vegas Technology and Innovation Conference
March 25, 2025
Via
Investor Brand Network
Clene to Participate in Jones Las Vegas Technology and Innovation Conference on April 8-9, 2025
March 25, 2025
SALT LAKE CITY - March 25, 2025 (NEWMEDIAWIRE) - Clene Inc. (NASDAQ: CLNN), along with its subsidiaries, “Clene” and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage...
Via
TheNewswire.com
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
